In this short piece I’ll step into the signatory seat and explain what risk assessment actually looks like when I review a job bag: not a sterile tick-box exercise, but a live weighing of audience, co
Anzal Qurbain
Jan 9, 2026 • 10 Minutes Read
Jan 6, 2026
I still remember the LinkedIn post that landed in my inbox at 7:30 a.m. — a well-meaning disease-awareness graphic shared by a global team, liked by a
8 Minutes Read
Dec 16, 2025
Tired teams, last-minute campaigns, and a swirl of regulatory updates — the Christmas run-up in pharma is always a mixing pot of reflection and resolv
Dec 3, 2025
Let me tell you about a moment in 2024 that jolted me: an utterly compliant disease-awareness campaign unravelled because a single social media image
7 Minutes Read
Nov 26, 2025
Is your final abpi signatory choking your marketing efforts! Are you an overly cautious signatory? well read on, how the ABPI Code defends (not deters
11 Minutes Read
Nov 18, 2025
I have seen the supposedly innocent disease-awareness flyers! If you think ‘non-promotional’ means ‘risk-free,’ you’re in for a surprise – and so was
Nov 10, 2025
TL;DR: If your sponsorship declaration isn’t crystal-clear, up-front, and brutally honest about influence? It’s non-compliant. Tidy up your wording, l
6 Minutes Read
Nov 3, 2025
A brand manager surprised me when she asked me if the new ad was ‘balanced’. I think she said it with the hope that I’d just nod and move on. Instead,
10 Minutes Read
Oct 25, 2025
Every spring and summer, the congress season breathes energy into the pharmaceutical world—a moment brimming with anticipation for product progress, e
Oct 18, 2025
Every congress season, the influx of last-minute speaker decks exposes a familiar vulnerability in pharmaceutical communications. Speed, while necessa
Oct 13, 2025
Let me take you behind the scenes of a Jazz Pharmaceuticals case that could have happened to any of us. In my early years as a final signatory I found
